Solta

Hayward, United States Founded: 1995 • Age: 31 yrs Listed Acquired By Bausch Health
Energy-based aesthetic medical devices are designed and marketed.

About Solta

Solta is a company based in Hayward (United States) founded in 1995 was acquired by Bausch Health in December 2013. The company has 6,355 employees. Solta has completed 2 acquisitions, including Liposonix and Sound Surgical Technologies. Solta offers products and services including Thermage FLX, Clear+Brilliant, Fraxel, and VASERlipo. Solta operates in a competitive market with competitors including Cutera, Lumenis, MedShift, Cartessa Aesthetics and InMode Aesthetic Solutions, among others.

  • Headquarter Hayward, United States
  • Employees 6,355
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    •••• ••••
  • Website solta.com
  • Social LinkedIn X
  • Acquired by Bausch Health (Dec 2013)
  • Legal Name Solta Medical Inc.
Operational Areas
Key Metrics
  • Annual Revenue
    $596.47 (USD)
    -78
    as on Dec 31, 2022
  • Net Profit
    -$145.04 (USD)
    93
    as on Dec 31, 2023
  • Latest Funding Round
    $40M (USD), Debt – Venture

    Nov 2013

  • Investors
  • Employee Count
    6,355
  • Investments & Acquisitions
    Liposonix

    & 1 more

  • Acquired by
    Bausch Health

    (Dec 2013)

Products & Services of Solta

Solta offers a comprehensive portfolio of products and services, including Thermage FLX, Clear+Brilliant, Fraxel, and VASERlipo.

Thermage FLX
Skin Resurfacing Device

Non-invasive radiofrequency device for treating wrinkles and skin tightening.

Clear+Brilliant
Laser Resurfacing Device

Non-ablative laser for improving skin tone and reducing fine lines.

Fraxel
Fractional Laser Device

Laser system for skin resurfacing and treatment of pigmentation issues.

VASERlipo
Body Contouring Device

Ultrasonic system for fat removal and aesthetic body shaping.

Funding Insights of Solta

  • Total Rounds 5
  • Last Round Debt – Venture — $40M
  • First Round $17.2M

    (Jan 2010)

  • Investors Count 3

All 5 funding rounds of Solta with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2013$40MDebt – Venture––
Apr 2013$25.5MPost-IPO––
–
Mar 2010$4.75MPost-IPO––
–
Jan 2010$17.23MPost-IPO––
Jan 2010$17.2MPost-IPO––
–
Valuation history

4 investors in total: 4 institutional.

Investors in Solta

Solta has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Bausch Health, CRG and Great Point Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
CRG is recognized as a premier healthcare investment partner.
–crglp.comHouston, United States
Private equity firm focused on company buyouts
–gppfunds.comGreenwich, United States
Private equity firm focused on life science sector
–longitudecapital.comMenlo Park, United States
Therapeutics for multiple diseases including dermatology and neurology are developed.
1960bauschhealth.comLaval, Canada
Premium access

Investor details for Solta

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Solta

Solta has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Liposonix and Sound Surgical Technologies.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Aesthetic devices for skin tightening and body treatments are developed.
soundsurgical.comLouisville, United States1998Jan 2013$30.5M
Non-surgical and non-invasive treatment to eliminate unwanted fat around waistline
liposonix.comHayward, United States1999Sep 2011••••
Premium access

Complete acquisition details for Solta

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Solta

7 dated milestones of Solta across 18 years, from founding to its latest funding, stage changes and deals.

  1. Founded Solta is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $17.2M.
  4. Acquisition Acquires Liposonix.
  5. Acquisition Acquires Sound Surgical Technologies.
  6. Funding Latest funding round, Debt – Venture, of $40.0M.
  7. Exit Acquired by Bausch Health.

Competitors of Solta

Solta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cutera, Lumenis, MedShift, Cartessa Aesthetics and InMode Aesthetic Solutions, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cutera.com1998Brisbane, United States–540
Energy-based aesthetic devices are developed for medical treatments.
lumenis.com1973Yokneam Illit, Israel––
Minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets
medshift.com2015Charlotte, United States$116M–
Medical practice management services
cartessaaesthetics.com2017New York, United States$60M129
Aesthetic medical devices
inmodemd.com2008Lake Forest, United States–171
Develops a portfolio of aesthetic solutions
almalasers.com1980Buffalo Grove, United States–48
Portfolio of optical, radiofrequency and ultrasound devices for aesthetic & medical applications
strataskinsciences.com1989Horsham, United States–114
Developer of medical devices to treat skin diseases
silkn.com2006Richmond Hill, Canada––
Home-use aesthetic devices
Premium access

Detailed competitors of Solta

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Solta

The website of Solta (solta.com) receives about 9.1K visits a month.

  • Monthly visits
    9.1K

    ▼ 9.7% vs previous month

Similar websites

Websites whose visitors overlap most with Solta. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cutera.com
100%
33.6K–View details
cynosure.com
91%
52.9K#629,074View details
liposonix.com
90%
––View details
syneron-candela.com
85%
––View details
vioramed.com
78%
––View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 8 similar websites and full traffic analytics for Solta

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 8 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Solta

Premium access

Complete news archive for Solta

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Solta

10 companies that operate in the same segment as Solta (Dermatology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
2002Newark, New Jersey, United StatesUSD 154.56 MUSD 234.04 M597
Diagnostic tests for cancer prognosis are provided.
2008Friendswood, Texas, United StatesUSD 61.97 MUSD 344.23 M761
Developer of drugs for treating dermatology diseases
1908Copenhagen, DenmarkUSD 560.38 M––
Skincare, beauty, and wellness services provided by VLCC across multiple countries.
1989Delhi, Delhi, India–––
Adhesive patch biopsies for skin cancer detection are provided.
1996San Diego, California, United StatesUSD 24.37 MUSD 15.3 M259
AI-powered drug discovery platform for various diseases
2016New York, New York, United StatesUSD 608 M––
Immunotherapeutic solutions for dermatological conditions are developed.
2016Westlake Village, California, United StatesUSD 94.5 MUSD 376.07 M342
Targeted small molecules are developed for oncology treatments.
2010Singapore, SingaporeUSD 100 M––
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured.
2014Pune, Maharashtra, IndiaUSD 25.97 MUSD 18.15 M508
Novel dermatologic therapies are developed for skin conditions.
2012Malvern, Pennsylvania, United StatesUSD 82 MUSD 7.83 M64
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Solta

Solta was founded in 1995 and raised its 1st funding round 15 years after it was founded.

Solta is headquartered in Hayward, United States. It is registered at Hayward, California, United States.

Solta has 6,355 employees.

Annual revenue of Solta is $596.47 as on Dec 31, 2022.

Solta Medical was founded in 1995 and is headquartered in Hayward, United States. Operations focus on the aesthetic medicine sector, where energy-based device systems are designed, developed, manufactured, and marketed. Key products include Isolaz for acne treatment via vacuum and light, Thermage for non-invasive wrinkle reduction, and Liposonix for fat reduction, alongside other aesthetic applications.

Solta's top competitors include Lumenis, Cartessa Aesthetics and Cutera.

Solta offers Thermage FLX, Clear+Brilliant, Fraxel, and VASERlipo.

Solta has made 2 acquisitions, including Liposonix, and Sound Surgical Technologies.

Solta has 4 investors. Key investors include Bausch Health, CRG, Great Point Partners, and Longitude Capital.

Solta operates through Solta Medical Inc..

Yes. Solta was acquired by Bausch Health in December 2013.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available